Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
Neuroreport|June 11, 1999
Categorical and coordinate spatial relations: fMRI evidence for hemispheric specializationM Baciu, O Koenig, M P Vernier, et al.Journal of Neurochemistry|November 1, 1988
Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the ratP Vernier, J F Julien, P Rataboul, et al.European Journal of Biochemistry|March 1, 1994
Transcription of the rat dopamine-D2-receptor gene from two promotersO Valdenaire, P Vernier, M Maus, et al.Brain Research Bulletin|January 1, 1989
Modulation of GFAP mRNA levels following toxic lesions in the basal ganglia of the ratP Rataboul, P Vernier, N F Biguet, et al.Brain Research|February 3, 1987
Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the ratL Paturle, D Fage, O Fourrier, et al.Molecular Endocrinology (Baltimore, Md.)|May 29, 2001
Differential subcellular distribution and transcriptional activity of sigmaE3, sigmaE4, and sigmaE3-4 isoforms of the rat estrogen receptor-alphaC Pasqualini, D Guivarc'h, J V Barnier, et al.Endocrinology|May 26, 1999
Stage- and region-specific expression of estrogen receptor alpha isoforms during ontogeny of the pituitary glandC Pasqualini, D Guivarc'h, Y V Boxberg, et al.Journal De La Societe De Biologie|December 1, 2000
[Evolution and development of dopaminergic neurotransmitter systems in vertebrates]M Kapsimali, H Dumond, S Le Crom, et al.Journal of Receptor Research|January 1, 1993
D2-dopaminergic agonist quinpirole and 8-bromo-cAMP have opposite effects on Go alpha GTP-binding protein mRNA without changing D2 dopamine receptor mRNA levels in striatal neurones in primary cultureM Maus, P Vernier, O Valdenaire, et al.Journal of Neurochemistry|February 1, 1991
Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonistJ Caboche, P Vernier, J F Julien, et al.Pageof 6